Method for purifying ropinirole hydrochloride

US10961194B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10961194-B2
Application numberUS-201716623085-A
CountryUS
Kind codeB2
Filing dateJun 16, 2017
Priority dateJun 16, 2017
Publication dateMar 30, 2021
Grant dateMar 30, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a method for purifying ropinirole hydrochloride (4-2-di-n-propylaminoethyl-1,3-dihydro-2H-indole-2-ketohydrochloride). The method comprises: adding ropinirole hydrochloride containing a monopropyl impurity A into water, adding organic solvent, stirring and dissolving at room temperature, adding alkali, stirring, standing, demixing, and removing an aqueous layer; optionally, drying the organic layer by using anhydrous magnesium sulfate, and filtering; and adding acyl chloride or acid anhydride into the organic layer, stirring, concentrating the organic layer to be dry, adding an organic solvent into the obtained oily matter, adding concentrated hydrochloric acid, and stirring, so as to obtain the ropinirole hydrochloride. By using the method, the impurity A in the ropinirole hydrochloride can be effectively removed, and the ropinirole hydrochloride can be obtained with a high yield and a high purity, so that the impurity A is controlled and the purity of the product reaches a medicinal standard.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for purifying ropinirole hydrochloride, 4-(2-di-n-propylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride, represented by a structural formula (II), comprising the following steps: wherein —R represents C 1 -C 6 alkyl or C 6 -C 10 aromatic group; -L represents halogen —X, or acyloxy (1) mixing ropinirole hydrochloride containing an impurity A, monopropyl ropinirole, represented by a structural formula (I) with water and an organic solvent, stirring and dissolving to obtain a clear solution at room temperature, adding an alkali, stirring, standing for demixing, and removing an aqueous layer, wherein the organic solvent is an aprotic solvent; and the alkali is a hydroxide, carbonate or bicarbonate of an alkali metal or alkaline earth metal, or an amine mono- or polysubstituted by C 1 -C 6 alkyl; (2) drying an organic layer obtained over anhydrous magnesium sulfate and filtering; or subjecting the organic layer obtained directly to a next step without addition of anhydrous magnesium sulfate; (3) adding acid halide or acid anhydride of a structural formula (IV) to the dried organic layer, stirring and concentrating; and (4) after concentrating to dryness to obtain an oily substance, adding an organic solvent to the obtained oily substance, adding a concentrated hydrochloric acid, and stirring to obtain ropinirole hydrochloride, wherein the organic solvent is an alcohol. 2. The method according to claim 1 , wherein in step (1) the volume of the organic solvent in milliliters is 2 to 20 times of the mass of ropinirole hydrochloride in grams, and the volume of water in milliliters is 5 to 20 times of the mass of ropinirole hydrochloride in grams. 3. The method according to claim 1 , wherein the molar amount of the alkali in step (1) is 1.5 to 25 times of the molar amount of ropinirole hydrochloride. 4. The method according to claim 1 , wherein the organic solvent in step (1) is dichloromethane, n-hexane, cyclohexane, ethyl acetate, isopropyl acetate, toluene, xylene or methyl tert-butyl ether. 5. The method according to claim 1 , wherein the alkali in step (1) is selected from the group consisting of sodium carbonate, potassium hydroxide, sodium hydroxide, potassium carbonate, sodium bicarbonate, triethylamine and diisopropylamine. 6. The method according to claim 1 , wherein the acid halide or acid anhydride in step (3) is selected from the group consisting of acetyl chloride, propionyl chloride, benzoyl chloride, acetic anhydride and benzoic anhydride, and the molar amount of the acid halide or acid anhydride is 1 to 5 times of the molar amount of impurity A. 7. The method according to claim 6 , wherein the acid halide or acid anhydride is selected from the group consisting of acetyl chloride, benzoyl chloride and acetic anhydride. 8. The method according to claim 1 , wherein the volume of the organic solvent in milliliters in step (4) is 2 to 20 times of the mass of ropinirole hydrochloride in grams. 9. The method according to claim 1 , wherein the molar amount of the concentrated hydrochloric acid in step (4) is 2 to 10 times of the molar amount of ropinirole hydrochloride. 10. The method according to claim 1 , wherein the organic solvent in step (4) is methanol, ethanol, isopropanol or n-butanol. 11. The method according to claim 2 , wherein the acid halide or acid anhydride in step (3) is selected from the group consisting of acetyl chloride, propionyl chloride, benzoyl chloride, acetic anhydride and benzoic anhydride, and the molar amount of the acid halide or acid anhydride is 1 to 5 times of the molar amount of impurity A. 12. The method according to claim 3 , wherein the acid halide or acid anhydride in step (3) is selected from the group consisting of acetyl chloride, propionyl chloride, benzoyl chloride, acetic anhydride and benzoic anhydride, and the molar amount of the acid halide or acid anhydride is 1 to 5 times of the molar amount of impurity A. 13. The method according to claim 11 , wherein the acid halide or acid anhydride is selected from the group consisting of acetyl chloride, benzoyl chloride and acetic anhydride. 14. The method according to claim 12 , wherein the acid halide or acid anhydride is selected from the group consisting of acetyl chloride, benzoyl chloride and acetic anhydride. 15. The method according to claim 2 , wherein the volume of the organic solvent in milliliters in step (4) is 2 to 20 times of the mass of ropinirole hydrochloride in grams. 16. The method according to claim 3 , wherein the volume of the organic solvent in milliliters in step (4) is 2 to 20 times of the mass of ropinirole hydrochloride in grams. 17. The method according to claim 2 , wherein the molar amount of the concentrated hydrochloric acid in step (4) is 2 to 10 times of the molar amount of ropinirole hydrochloride. 18. The method according to claim 3 , wherein the molar amount of the concentrated hydrochloric acid in step (4) is 2 to 10 times of the molar amount of ropinirole hydrochloride. 19. The method according to claim 2 , wherein the organic solvent in step (4) is methanol, ethanol, isopropanol or n-butanol. 20. The method according to claim 3 , wherein the organic solvent in step (4) is methanol, ethanol, isopropanol or n-butanol.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10961194B2 cover?
Provided is a method for purifying ropinirole hydrochloride (4-2-di-n-propylaminoethyl-1,3-dihydro-2H-indole-2-ketohydrochloride). The method comprises: adding ropinirole hydrochloride containing a monopropyl impurity A into water, adding organic solvent, stirring and dissolving at room temperature, adding alkali, stirring, standing, demixing, and removing an aqueous layer; optionally, drying t…
Who is the assignee on this patent?
Zhejiang Huahai Licheng Pharmaceutical Co Ltd, Zhejiang Huahai Pharm Co Ltd, Zhejiang Huahai Pharmaceuticals Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D209/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).